| 000 | 01618 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515193453.0 | ||
| 264 | 0 | _c20100225 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1938-3673 | ||
| 024 | 7 |
_a10.1189/jlb.0609388 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLappas, Courtney M | |
| 245 | 0 | 0 |
_aAdenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation. _h[electronic resource] |
| 260 |
_bJournal of leukocyte biology _cFeb 2010 |
||
| 300 |
_a345-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdenosine A2 Receptor Agonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, CD _ximmunology |
| 650 | 0 | 4 |
_aCD4-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCD8-Positive T-Lymphocytes _ximmunology |
| 650 | 0 | 4 |
_aCyclohexanecarboxylic Acids _xpharmacology |
| 650 | 0 | 4 |
_aCytokines _ximmunology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aGraft vs Host Disease _xdrug therapy |
| 650 | 0 | 4 | _aHematopoietic Stem Cell Transplantation |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aPurines _xpharmacology |
| 650 | 0 | 4 |
_aReceptor, Adenosine A2A _ximmunology |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 700 | 1 | _aLiu, Po-Ching | |
| 700 | 1 | _aLinden, Joel | |
| 700 | 1 | _aKang, Elizabeth M | |
| 700 | 1 | _aMalech, Harry L | |
| 773 | 0 |
_tJournal of leukocyte biology _gvol. 87 _gno. 2 _gp. 345-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1189/jlb.0609388 _zAvailable from publisher's website |
| 999 |
_c19277825 _d19277825 |
||